"Viral Fusion Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.
| Descriptor ID |
D014760
|
| MeSH Number(s) |
D12.776.543.512.500 D12.776.964.970.880.910
|
| Concept/Terms |
Viral Fusion Proteins- Viral Fusion Proteins
- Virus Fusion Proteins
- Fusion Proteins, Virus
- Proteins, Virus Fusion
- Fusion Proteins, Viral
Viral Fusion Glycoproteins- Viral Fusion Glycoproteins
- Fusion Glycoproteins, Viral
- Glycoproteins, Viral Fusion
- Glycoprotein, Viral Fusion
- Viral Fusion-GP
- Fusion-GP, Viral
- Viral Fusion GP
- Fusion Glycoprotein, Viral
- Viral Fusion Glycoprotein
|
Below are MeSH descriptors whose meaning is more general than "Viral Fusion Proteins".
Below are MeSH descriptors whose meaning is more specific than "Viral Fusion Proteins".
This graph shows the total number of publications written about "Viral Fusion Proteins" by people in this website by year, and whether "Viral Fusion Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 7 | 3 | 10 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 24 | 3 | 27 |
| 2018 | 17 | 6 | 23 |
| 2019 | 9 | 2 | 11 |
| 2020 | 4 | 1 | 5 |
| 2021 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Fusion Proteins" by people in Profiles.
-
Response to the letter, entitled "Role of hemagglutinin esterase protein in neurological manifestation of COVID-19". Fluids Barriers CNS. 2021 09 03; 18(1):41.
-
Role of hemagglutinin esterase protein in neurological manifestation of COVID-19. Fluids Barriers CNS. 2021 08 16; 18(1):39.
-
The Need for Community Standards to Enable Accurate Comparison of Glycoproteomics Algorithm Performance. Molecules. 2021 Aug 06; 26(16).
-
Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19. Mol Divers. 2021 Aug; 25(3):1999-2000.
-
Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology? Stem Cell Rev Rep. 2021 12; 17(6):2359-2360.
-
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis. Front Immunol. 2021; 12:683902.
-
Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection. Microbes Infect. 2021 Sep-Oct; 23(8):104840.
-
Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model. Proc Natl Acad Sci U S A. 2021 05 04; 118(18).
-
SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2. J Mol Biol. 2021 05 14; 433(10):166946.
-
Pan-coronavirus fusion inhibitors as the hope for today and tomorrow. Protein Cell. 2021 02; 12(2):84-88.